• Awards and Scholarships
• SVS Lifetime Achievement Award
• SVS Medal for Innovation in Vascular Surgery
• SVS Clinical Research Seed Grants
• Health Policy Scholarship
• International Scholars Program
• AVA/Lifeline Awards
• Awards From Other Societies
• Other Awards
• American Vascular Association

Home > Medical Professionals > Awards and Scholarships > SVS Clinical Research Seed Grants

SVS Clinical Research Seed Grants

2008 Award Winners

Dr. Fritz Bech Palo Alto Institute of Research & Education Dr. David Cassada University of Tennessee Graduate School of Medicine Dr. Rabih Chaer University of Pittsburgh

2007 Award Winners

Dr. Greg Landry Oregon Health and Science University Dr. Maureen Sheehan University of Texas San Antonio Dr. Mark Wyers Dartmouth Hitchcock Medical Center

In recognition of the growing importance of clinical investigation in vascular disease, SVS has established the Clinical Research Seed Grant program.

Purpose: It is vitally important, both to patients and to the specialty, that vascular surgeons play prominent roles in both industry and investigator-initiated clinical trials. The Clinical Research Seed Grant program has the following goals:

• Encourage the interest and development of clinical trialists among the SVS membership, particularly junior members or those with limited prior experience as Principal Investigators
• Provide direct support for pilot clinical projects that have potential to develop into larger studies fundable by industry or governmental sources

Scope: Clinical research, preferably patient-oriented (NIH defines patient-oriented research as research conducted with human subjects or on material of human origin such as tissues, specimens and cognitive phenomena for which an investigator directly interacts with human subjects). Small-scale clinical trials and ancillary studies in the setting of existing clinical trials (industry or NIH-supported) are particularly encouraged. Relevant examples include:

• Ancillary studies coupled to existing clinical trials to develop/test biomarkers, surrogate imaging, physiologic, or quality of life endpoints. Letter of support from the primary trial sponsor would be required
• Pilot clinical trials of all types
• Studies on the natural history of vascular disease, pathophysiology, or on the mechanisms underlying the success or failure of vascular interventions
• Application of quality-of-life, functional status, and resource utilization measures to assess the impact of vascular interventions
• Development and validation of clinical risk-prediction models or diagnostic tools
• Studies addressing the nature of disparities in care and outcomes

Contact: Society for Vascular Surgery, Phone: 800-258-7188, Fax: 312-334-2320, Email: vascular@vascularsociety.org.